Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial.

Authors

Jonathan I. Silverberg, George Washington University
Eric L Simpson
Jacob P Thyssen
Melinda Gooderham
Gary Chan
Claire Feeney
Pinaki Biswas
Hernan Valdez
Marco DiBonaventura
Chudy Nduaka
Ricardo Rojo

Document Type

Journal Article

Publication Date

6-3-2020

Journal

JAMA Dermatology

DOI

10.1001/jamadermatol.2020.1406

Comments

Online ahead of print

APA Citation

Silverberg, J. I., Simpson, E., Thyssen, J., Gooderham, M., Chan, G., Feeney, C., Biswas, P., Valdez, H., DiBonaventura, M., Nduaka, C., & Rojo, R. (2020). Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial.. JAMA Dermatology, (). http://dx.doi.org/10.1001/jamadermatol.2020.1406

Peer Reviewed

1